ScreenerHero
STXShield Therapeutics plc
LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · shieldtherapeutics.com
6.200GBp+1.64%Mkt Cap: 72.08M $P/E: —

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Fera…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
vs Drug Manufacturers - Specialty & Generic
1M Perf
Avg
MRK
Merck KGaA
$69.40BUSDP/E 25.2
UTHR
United Therapeutics Corporation
$23.00BUSDP/E 20.0
VTRS
Viatris Inc.
$18.49BUSD
NBIX
Neurocrine Biosciences, Inc.
$16.95BUSDP/E 26.0
SOBI
Swedish Orphan Biovitrum AB (publ)
$15.35BUSDP/E 175.0
IPN
Ipsen S.A.
$15.16BUSDP/E 31.8
ELAN
Elanco Animal Health Incorporated
$12.29BUSD
KRK
Krka, d. d.
$8.30BUSDP/E 21.1
HIMS
Hims & Hers Health, Inc.
$8.02BUSD
LNTH
Lantheus Holdings, Inc.
$7.22BUSDP/E 26.5
LQDA
Liquidia Corporation
$7.09BUSDP/E 469.0
AMRX
Amneal Pharmaceuticals, Inc.
$5.52BUSDP/E 46.8
SFZN
Siegfried Holding AG
$3.54BUSDP/E 18.4
HIK
Hikma Pharmaceuticals PLC
$3.48BUSDP/E 11.1
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.22BUSDP/E 22.4
ALM
Almirall, S.A.
$2.66BUSDP/E 59.3
SUPN
Supernus Pharmaceuticals, Inc.
$2.70BUSD
DMP
Dermapharm Holding SE
$2.54BUSDP/E 17.6
BCRX
BioCryst Pharmaceuticals, Inc.
$2.54BUSD
PBH
Prestige Consumer Healthcare Inc.
$2.24BUSDP/E 12.1
FAGR
Fagron NV
$1.92BUSDP/E 19.4
AMLX
Amylyx Pharmaceuticals, Inc.
$2.00BUSD
PPGN
PolyPeptide Group AG
$1.77BUSD
ANIP
ANI Pharmaceuticals, Inc.
$1.88BUSDP/E 21.2
BHC
Bausch Health Companies Inc.
$1.90BUSD
FAE
Faes Farma, S.A.
$1.56BUSDP/E 18.4
HROW
Harrow, Inc.
$1.58BUSD
XERS
Xeris Biopharma Holdings, Inc.
$1.37BUSDP/E 113.1
PAHC
Phibro Animal Health Corporation
$1.27BUSDP/E 13.5
BIOG-B
BioGaia AB (publ)
$1.13BUSDP/E 35.6
COLL
Collegium Pharmaceutical, Inc.
$1.17BUSDP/E 17.6
ECILC
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.
$1.23BUSD
BIOA
BioAge Labs, Inc.
$1.09BUSD
CRON
Cronos Group Inc.
$1.07BUSDP/E Infinity
EVT
Evotec SE
$964.80MUSD
PCRX
Pacira BioSciences, Inc.
$998.26MUSDP/E 195.2
ETON
Eton Pharmaceuticals, Inc.
$991.60MUSD
PHN
Pharmanutra S.p.A.
$912.76MUSDP/E 39.9
VETO
Vetoquinol SA
$895.85MUSDP/E 14.4
AMPH
Amphastar Pharmaceuticals, Inc.
$889.80MUSDP/E 12.2
ESPR
Esperion Therapeutics, Inc.
$814.31MUSDP/E Infinity
IRWD
Ironwood Pharmaceuticals, Inc.
$693.02MUSDP/E 6.8
GUD
Knight Therapeutics Inc.
$704.28MUSDP/E 164.2
BOI
Boiron SA
$522.76MUSDP/E 14.7
AQST
Aquestive Therapeutics, Inc.
$521.87MUSD
AGY
Allergy Therapeutics plc
$488.71MUSD
EOLS
Evolus, Inc.
$457.03MUSD
WEED
Canopy Growth Corporation
$450.66MUSD
EBS
Emergent BioSolutions Inc.
$432.38MUSD
SCYX
SCYNEXIS, Inc.
$323.33MUSD
ATB
Antibiotice S.A.
$317.55MUSDP/E 43.3
ORGO
Organogenesis Holdings Inc.
$312.68MUSD
DEVA
Deva Holding A.S.
$342.71MUSD
AKBA
Akebia Therapeutics, Inc.
$305.81MUSD
TKNO
Alpha Teknova, Inc.
$304.53MUSD
LAVI
Lavipharm S.A.
$288.10MUSDP/E 51.7
CPH
Cipher Pharmaceuticals Inc.
$308.25MUSDP/E 9.9
BIO
Biofarm S.A.
$294.94MUSDP/E 15.2
CLN
Celon Pharma S.A.
$268.98MUSDP/E 9.7
ANCR
Animalcare Group plc
$250.67MUSDP/E 47.7
SIGA
SIGA Technologies, Inc.
$261.08MUSDP/E 13.0
RJF
Laboratorio Reig Jofre, S.A.
$239.98MUSDP/E 53.8
LFCR
Lifecore Biomedical, Inc.
$196.92MUSD
DERM
Journey Medical Corporation
$194.94MUSD
ANIK
Anika Therapeutics, Inc.
$194.66MUSD
XLY
Auxly Cannabis Group Inc.
$182.70MUSDP/E 8.8
ACB
Aurora Cannabis Inc.
$178.18MUSD
PHO
Photocure ASA
$147.49MUSDP/E 18.8
ASRT
Assertio Holdings Inc
$151.86MUSD
EAPI
Euroapi S.A.
$138.58MUSD
OGI
Organigram Global Inc.
$148.14MUSD
CRDL
Cardiol Therapeutics Inc.
$125.08MUSD
RX
BioSyent Inc.
$119.66MUSDP/E 18.6
HLS
HLS Therapeutics Inc.
$100.44MUSD
CPIX
Cumberland Pharmaceuticals Inc.
$97.09MUSD
VISTN
Vistin Pharma ASA
$85.39MUSDP/E 12.3
ORX
Orexo AB (publ)
$80.64MUSD
EQL
EQL Pharma AB
$66.94MUSDP/E 56.4
AB
AB Science S.A.
$67.12MUSD
NANEXA
Nanexa AB (publ)
$64.16MUSD
EAH
ECO Animal Health Group plc
$66.36MUSDP/E 22.8
ENZY
Enzymatica AB (publ)
$55.72MUSD
CTOR
Citius Oncology, Inc.
$60.45MUSD
CINPHA
Cinclus Pharma Holding AB (publ)
$48.97MUSD
TLPH
Talphera, Inc.
$53.46MUSD
DB
Decibel Cannabis Company Inc.
$50.41MUSD
MOB
Moberg Pharma AB (publ)
$42.17MUSD
BTAI
BioXcel Therapeutics, Inc.
$43.54MUSD
MLC
Malin Corporation plc
$35.03MUSDP/E Infinity
PXS
Provexis plc
$32.51MUSD
TRILC
Turk Ilac Ve Serum Sanayi Anonim Sirketi
$29.51MUSD
TXMD
TherapeuticsMD, Inc.
$25.58MUSDP/E 221.0
AYTU
Aytu BioPharma, Inc.
$23.08MUSD
ROMJ
Rubicon Organics Inc.
$23.13MUSD
RMTI
Rockwell Medical, Inc.
$21.73MUSD
LABS
MediPharm Labs Corp.
$21.66MUSD
KLAR
Klaria Pharma Holding AB (publ.)
$18.56MUSD
VM
Voyageur Pharmaceuticals Ltd.
$16.34MUSD
MEDIC
Medicon Hellas S.A.
$14.36MUSDP/E 17.5
APUS
Apimeds Pharmaceuticals US, Inc.
$13.58MUSD
BFRI
Biofrontera Inc.
$12.11MUSD
CABR
Caring Brands, Inc.
$11.27MUSD
AVCN
Avicanna Inc.
$11.45MUSD
MPH
Medicure Inc.
$9.80MUSD
PCLO
PharmaCielo Ltd.
$8.90MUSD
YCBD
cbdMD, Inc.
$7.07MUSDP/E 0.3
STENO
Stenocare A/S
$6.32MUSD
SNOA
Sonoma Pharmaceuticals, Inc.
$5.89MUSD
NUTEX
NUTEX Investments Public Limited Company
$4.95MUSDP/E 4.0
MUSH
Mercanto Holdings Inc.
$5.64MUSDP/E Infinity
EGRX
Eagle Pharmaceuticals, Inc.
$3.29MUSDP/E 1.4
GABA
Gabather AB (publ)
$2.15MUSD
ERMA
Enorama Pharma AB (publ)
$1.93MUSD
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$1.90MUSDP/E 32.5
CANB
CanadaBis Capital Inc.
$1.54MUSD
GENX
Genix Pharmaceuticals Corporation
$668.8KUSD
PTPI
Petros Pharmaceuticals, Inc.
$216.1KUSDP/E 0.0
CLVR
Clever Leaves Holdings Inc.
$350USD
Indicators:|

Key Statistics

Company
Market Cap72.08M $
Enterprise Value92.13M $
Revenue (TTM)54.02M $
Gross Profit25.04M $
Net Income (TTM)-19.19M $
Revenue/Share0.0511 USD
Last Price6.200 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees61
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.27
PEG—
EV/EBITDA-8.63
EV/Revenue1.71
P/S1.33
P/B-5.86
EPS (TTM)-0.02
EPS (Forward)0.01
52W Range
2.70036% of range12.50
52W High12.50 GBp
52W Low2.700 GBp
Profitability
Gross Margin46.36%
Oper. Margin-15.07%
EBITDA Margin-19.76%
Profit Margin-35.52%
ROE117.10%
ROA-27.07%
Growth
Revenue Growth40.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.67M $
CapEx (TTM)326.09K $
FCF Margin12.56%
FCF Yield9.41%
Net Debt20.12M $
Net Debt/EBITDA-1.88
Balance Sheet
Debt/Equity-2.00
Current Ratio0.90
Quick Ratio0.67
Book Value/Sh-0.0106 GBp
Cash/Share0.0110 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.67 GBp
Upside (mean)+168.8%
Target Range12.00 GBp – 23.00 GBp
GBp12.00+168.8% to meanGBp23.00
# Analysts3
Ownership
Shares Out.1.07B
Float411.58M
Insiders61.77%
Institutions3.34%
Technical
SMA 506.846 (-9.4%)
SMA 2008.523 (-27.3%)
Beta1.78
S&P 52W Chg20.05%
Avg Vol (30d)1.65M
Avg Vol (10d)697.35K
Technical Indicators
RSI (14)43.0
MACD-0.1347
MACD Signal-0.1773
MACD Hist.+0.0426
BB Upper6.709 GBp
BB Middle6.205 GBp
BB Lower5.701 GBp
BB Width16.23%
ATR (14)0.3606 GBp
Vol Ratio (20d)0.18x